Qualigenix provides pathology billing services for pathology groups and laboratories: specimen-level coding, technical and professional component billing, molecular test authorization, requisition and eligibility follow-up, and denial appeals, delivered remotely to labs and groups in 48 states. Pathology labs bill for patients they never see, often from requisitions missing insurance data or a valid order. Qualigenix captures every specimen, splits technical and professional components correctly, and applies Medicare's date-of-service rules for hospital specimens.
Pathology billing means coding each specimen at the right level and unit count, billing the technical and professional components to the right party, and getting payer data from a requisition the lab didn't write. Medicare's date-of-service rule decides whether a test on a hospital specimen is billed by the lab or the hospital. Qualigenix handles each of these before the claim is sent. Book a free billing audit: 786-259-0231.
Surgical pathology codes (88302–88309) are billed per specimen, at a level set by the specimen type. Billing one unit for a case with several separately identified specimens, or the wrong level for the tissue, leaves money behind or invites an audit.
Genomic panels and molecular tests often need prior authorization, and many Medicare contractors require tests to be registered under the MolDX program before they're paid. A test run without either is usually denied.
The technical component (TC) covers the lab work and the professional component (26) covers the pathologist's interpretation. Who bills each depends on where the specimen was processed and who employs the pathologist. Billing the global code when only one component applies leads to denials or duplicate payments.
Under Medicare's date-of-service rule (42 CFR 414.510), a test on a specimen collected during a hospital encounter is usually billed by the hospital. The lab bills Medicare directly when the test is ordered at least 14 days after discharge, or when a molecular or advanced diagnostic test on a hospital outpatient specimen meets CMS's exception. Getting this wrong means billing the wrong party.
Labs receive specimens with incomplete patient data, missing insurance cards or no diagnosis code. Claims built from incomplete requisitions are rejected or sent to the wrong payer.
Every lab claim needs a valid order and the referring provider's NPI. A missing signature, missing NPI or diagnosis that doesn't support the test leads to denials that are hard to fix after the fact.
The most common pathology denials are unit overages beyond Medically Unlikely Edits (MUEs), missing orders and component mismatches. Unit and component checks at coding, and an order check at intake, catch them.
Labs can bill only tests within the scope of their CLIA certificate, and Medicare's anti-markup rule limits what a practice can charge for a purchased technical or professional component. Both are common audit targets.
Qualigenix fixes pathology billing at intake and coding, before a claim reaches the payer.
Our coders count each separately identified specimen and assign the right surgical pathology level and add-on codes. Qualigenix holds 98.9% coding accuracy across all specialties it codes.
We request prior authorizations for molecular and genomic tests, confirm MolDX registration where the contractor requires it, and track approvals against the specimen.
Each case is billed as global, TC or 26 based on where the work was done and the arrangement with the referring facility.
Tests on hospital specimens are checked against the date-of-service rule before billing, so each claim goes to the lab's payer or the hospital as the rule requires.
We fill gaps in patient and insurance data by contacting referring offices and verifying coverage before the claim is built.
Missing orders, signatures and diagnosis codes are requested from referring providers and logged before the claim goes out.
Missing-order denials are fixed with records from the referring office; unit and component denials are corrected and resubmitted. Qualigenix overturns 79% of the denials it works.
Claims are checked against the lab's CLIA scope, NCCI and MUE edits, and anti-markup limits before submission.
Claims go out with an under 24-hour average submission turnaround, payments are posted by test and payer, and unpaid claims are worked before they age. Reports show revenue by test type, referring provider and payer.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Billed per specimen at levels II through VI, based on the tissue examined.
Qualigenix bills pathology and lab services within the rules that govern them: the scope of each lab's CLIA certificate, Medicare's date-of-service rule, anti-markup limits on purchased components, NCCI and MUE edits, and ABNs for tests with coverage limits. All work is HIPAA-compliant.

Pathology groups and labs choose Qualigenix because it fixes requisition and order gaps before billing, which is where CMS finds nearly all pathology payment errors.
Qualigenix prices pathology billing after reviewing your case volume, test mix and payer mix. A free billing audit gives you a quote and shows where specimens are underbilled. Call 786-259-0231 to start.
You bill one unit for each separately identified and separately examined specimen, up to the payer's Medically Unlikely Edit limit. Multiple pieces of tissue from one site submitted together count as one specimen.
Yes. Qualigenix requests prior authorization for molecular and genomic tests, confirms MolDX registration where the Medicare contractor requires it, and tracks each approval against the specimen.
Yes. Qualigenix contacts referring offices for missing patient, insurance and order data, verifies coverage, and builds the claim once the requisition is complete. Most labs start with a free AR review.
We bill the technical component (TC) for the party that processed the specimen and the professional component (26) for the pathologist who interpreted it. When one entity does both, we bill the global code.
We check every test on a hospital specimen against Medicare's date-of-service rule. The lab bills Medicare directly when the test is ordered at least 14 days after discharge, or when a molecular or advanced diagnostic test on an outpatient specimen meets CMS's exception; otherwise the hospital usually bills it.
Qualigenix works with the laboratory and EHR systems labs already use and bills from your data without asking you to change systems. We confirm access and workflow during onboarding.
Qualigenix onboards new clients in 6 days on average. Call 786-259-0231 to set a start date.